Hiroshi Suehiro

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Adjuvant chemotherapy after complete resection in Stage I B-III A non-small cell lung cancer is recommended. Several clinical trials of adjuvant chemotherapy are now underway in Japan. Our institute also participates in adjuvant clinical trials, but slow patient recruitment is a problem. In this paper, we reported the current status of adjuvant chemotherapy(More)
  • 1